Emmessar Biotech and Nutrition Ltd

Ticker: EMMESSA
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
30.65
Market Cap
15.31
Debt/Equity
0.0000
ROE %
4.101
PB
1.9861
Promoter %
59.529
Pledge %
0.000
1Y Rev Growth %
2.745
5Y Rev Growth %
-11.661
NP Margin %
11.832
NP Margin 5Y Avg %
19.569

Trading Reference

1M Return %
21.140
6M Return %
-10.641
1Y Return %
-42.366
% Away 52W High
108.809
% Away 52W Low
18.798
Daily Volume
628
Investment Verdict
Hold
Score 73/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 34/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Emmessar Biotech and Nutrition Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above the resistance at the recent highs. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable outlook for a price increase in the medium term, with potential upside if momentum continues.
Upside Probability: 25%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Emmessar Biotech and Nutrition Ltd is a leading player in the biotechnology and nutritional sectors, dedicated to enhancing health and wellness. Catering to a diverse audience, including healthcare professionals and consumers, the company focuses on innovative solutions that meet the growing demand for quality health products. With a commitment to research and development, Emmessar stands out for its high-quality standards and ethical practices, making a significant impact in the industry.

  • Established leader in biotech and nutrition
  • Focus on health and wellness solutions
  • Innovative research and development
  • High-quality standards and ethical practices
  • Diverse product range for various needs

Investment Thesis

Emmessar Biotech and Nutrition Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth in the rapidly evolving biotech sector.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Expanding digital services segment offers a robust growth runway.
  • Valuation metrics indicate the stock is undervalued compared to industry peers.
  • Strategic focus on innovation and quality positions the company favorably.
  • Positive market trends in biotechnology support long-term growth prospects.

Opportunity vs Risk

Opportunities
  • Growing demand for health supplements
  • Expansion into new markets
  • Innovative product launches
  • Strong online sales growth
Risks ⚠️
  • Regulatory challenges in biotech
  • Intense competition in nutrition sector
  • Supply chain disruptions
  • Dependence on key suppliers

Peer Perspective

Emmessar Biotech trades at a discount to peers like Biocon and Dr. Reddy's, reflecting its growth challenges. A consistent improvement in margins could trigger a rerating, aligning it closer to its more established competitors.

Future Outlook

Emmessar Biotech and Nutrition Ltd is well-positioned for growth, driven by innovation and market demand; however, successful execution and stringent cost control will be crucial to fully realize its potential.

AI FAQs for Retail Users

  • Q: What does Emmessar Biotech and Nutrition Ltd do?
    A: Emmessar Biotech focuses on manufacturing and distributing pharmaceutical and nutritional products.
  • Q: Is Emmessar Biotech a profitable company?
    A: Profitability can vary; check recent financial reports for the latest performance.
  • Q: What are the risks of investing in Emmessar Biotech?
    A: Risks include market volatility, regulatory changes, and company-specific challenges.
  • Q: How can I buy shares of Emmessar Biotech?
    A: You can purchase shares through a registered stockbroker or online trading platform.
  • Q: Where can I find more information about Emmessar Biotech?
    A: Visit their official website or review financial news and stock analysis platforms.
📊 Stock Investment Checklist (100 Points)
Emmessar Biotech and Nutrition Ltd • Updated: 2025-09-16 20:41:53
  • 8
    Business
    High
    The sector shows potential with increasing health awareness, but competition is high.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, indicating weaker profitability.
  • 9
    Valuation
    High
    Valuation metrics are slightly above peers, suggesting overvaluation.
  • 6
    Balance
    Good
    Moderate debt levels with limited liquidity raise concerns.
  • 7
    Governance
    High
    Promoter holding is decent, but there are some pledging issues.
  • 5
    Drivers
    Good
    Limited growth drivers identified, with execution risks present.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100 • Risky
Emmessar Biotech and Nutrition Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 55/100
  • Market Confidence: 60/100


More Like This